- Home
- NSTS vs ALGS Comparison
NSTS vs ALGS Comparison
Compare NSTS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- ALGS
- Stock Information
- Founded
- NSTS 1921
- ALGS 2018
- Country
- NSTS United States
- ALGS United States
- Employees
- NSTS N/A
- ALGS N/A
- Industry
- NSTS Savings Institutions
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- ALGS Health Care
- Exchange
- NSTS Nasdaq
- ALGS Nasdaq
- Market Cap
- NSTS 63.0M
- ALGS 53.0M
- IPO Year
- NSTS N/A
- ALGS 2020
- Fundamental
- Price
- NSTS $11.34
- ALGS $9.86
- Analyst Decision
- NSTS
- ALGS Strong Buy
- Analyst Count
- NSTS 0
- ALGS 2
- Target Price
- NSTS N/A
- ALGS $60.00
- AVG Volume (30 Days)
- NSTS 5.5K
- ALGS 72.0K
- Earning Date
- NSTS 11-12-2025
- ALGS 11-05-2025
- Dividend Yield
- NSTS N/A
- ALGS N/A
- EPS Growth
- NSTS N/A
- ALGS N/A
- EPS
- NSTS N/A
- ALGS N/A
- Revenue
- NSTS $9,435,000.00
- ALGS $3,174,000.00
- Revenue This Year
- NSTS N/A
- ALGS N/A
- Revenue Next Year
- NSTS N/A
- ALGS N/A
- P/E Ratio
- NSTS N/A
- ALGS N/A
- Revenue Growth
- NSTS 69.39
- ALGS N/A
- 52 Week Low
- NSTS $10.13
- ALGS $3.76
- 52 Week High
- NSTS $13.32
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- NSTS 32.54
- ALGS 50.65
- Support Level
- NSTS $11.31
- ALGS $9.60
- Resistance Level
- NSTS $11.65
- ALGS $10.70
- Average True Range (ATR)
- NSTS 0.18
- ALGS 0.76
- MACD
- NSTS -0.03
- ALGS -0.02
- Stochastic Oscillator
- NSTS 3.62
- ALGS 41.30
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.